Kelly A Romano is of Athira Pharma, Inc.. Currently has a direct ownership of 80,715 shares of ATHA, which is worth approximately $57,307. The most recent transaction as insider was on Jun 24, 2024, when has been sold 27,400 shares (Common Stock) at a price of $2.42 per share, resulting in proceeds of $66,308. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.7K
0% 3M change
110.66% 12M change
Total Value Held $57,307

Kelly A Romano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
BUY
Open market or private purchase
$66,308 $2.42 p/Share
27,400 Added 25.34%
80,715 Common Stock
Jun 21 2024
BUY
Open market or private purchase
$33,900 $2.26 p/Share
15,000 Added 21.96%
53,315 Common Stock
Dec 02 2022
BUY
Open market or private purchase
$98,700 $3.29 p/Share
30,000 Added 43.91%
38,315 Common Stock
Mar 31 2022
BUY
Open market or private purchase
$104,880 $13.11 p/Share
8,000 Added 49.03%
8,315 Common Stock

Also insider at

UGI
UGI CORP Utilities
DORM
Dorman Products, Inc. Consumer Cyclical
KAR

Kelly A Romano

King Of Prussia, PA

Track Institutional and Insider Activities on ATHA

Follow Athira Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

News

Receive news related to Athira Pharma, Inc.

Track Activities on ATHA